Durvalumab with transarterial chemoembolisation for treating incurable locally advanced hepatocellular carcinoma [ID5124]
Awaiting development
Reference number: GID-TA11019
Expected publication date: TBC
Please note that following on from information received from the company, the timelines for this appraisal are to be confirmed. An update on the revised timelines will be provided when further information is available.